BSG guidance recommends switching to biosimilar infliximab

2016-10-14 The British Society of Gastroenterology (BSG) released new guidance in February 2016 recommending that stable patients be switched to biosimilar infliximab (CT-P13). Biosimilar infliximab, Remisima/Inflectra… Read More »

Consumer choice between generic and brand-name medicines in a small generics market

2016-10-12 Background Generics offer an opportunity to governments to contain pharmaceutical expenditures, as they are generally 10‒80% lower in price than the originator brand-name medicines. Belgium… Read More »

Differences between biosimilars and reference products

2016-10-10 A review of glycosylated biosimilars approved in the European Union (EU) and Japan has highlighted structural variances between biosimilars and their reference products [1]. Biosimilars… Read More »

Impact of generics on European budgets

2016-10-07 A report by the Germany-based Institute for Healthcare and Social Research (IGES) released on 16 November 2015 found that generics could contribute to reducing healthcare… Read More »

Pharmacists’ attitudes towards domestic generics in Afghanistan

2016-10-05 The aim of the study by Hassali et al. was to survey community pharmacists regarding their attitudes about the quality and price of locally manufactured… Read More »

Prescribing similar biotherapeutic products in Latin America

2016-10-03 Prescribing practices vary across different countries in Latin America and reveal gaps in understanding and in the use of distinguishable names for biologicals [1]. A… Read More »

Paediatric use of low-cost generic programs in the US

2016-09-30 Low-cost generic drug programs (LCGPs) in the US increase the affordability of prescription medication that can treat many common paediatric conditions. LCGPs are a loss-leader… Read More »

Generics market share in Europe

2016-09-28 Generics make a major contribution to the European drug supply, according to a report by the by Germany-based Institute for Healthcare and Social Research (IGES).… Read More »

Physicians’ and pharmacists’ perspectives on generics use

2016-09-26 The review study of Toverud et al. shows that both physicians and pharmacists have acknowledged strategies for generics use as an attempt to curtail increasing… Read More »

Barriers to biologicals competition

2016-09-23 As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to ‘large molecule’ biologicals. Although biologicals represent many of the most promising… Read More »

Page 6 of 49 1 ... « Previous4 5 6 7 8 Next »... 49
Go Back Print